Saartje Straetemans1, Jean De Schepper, Muriel Thomas, Franciska Verlinde, Raoul Rooman. 1. Department of Pediatric Endocrinology, University Hospital Maastricht, Maastricht, The Netherlands; NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands; The Belgian Society for Pediatric Endocrinology and Diabetology (BESPEED), Brussels, Belgium.
Abstract
BACKGROUND/AIM: To validate prediction models for near final adult height (nFAH) by Ranke et al. [Horm Res Paediatr 2013;79:51-67]. METHODS: Height data of 127 (82 male) idiopathic growth hormone (GH)-deficient children, treated with GH until nFAH, were retrieved from the database of the Belgian Society for Pediatric Endocrinology and Diabetology (BESPEED). nFAH was predicted after first-year GH treatment, applying prediction models by Ranke et al. Bland-Altman plots and Clarke error grid analyses were performed to assess clinical significance of the differences between observed and predicted nFAH. RESULTS: In males, the predicted nFAH was higher than the observed nFAH (difference: 0.2 ± 0.7 SD; p < 0.01). In females, there was no significant difference. Bland-Altman analyses showed that the means of the differences between observed and predicted nFAH were close but not equal to zero, with overprediction for smaller heights and underprediction for taller heights. Clarke error grid analysis: in males, 59-61% of the predicted nFAH were within 0.5 SDS and 88% within 1.0 SDS from the observed nFAH; in females, 40-44% of the predicted nFAH were within 0.5 SDS and 76-78% within 1.0 SDS from the observed nFAH. CONCLUSION: Ranke's models accurately predicted nFAH in females and overpredicted nFAH in males by about 1.5 cm. In most individuals, the predicted nFAH was within 1 SDS of observed nFAH. These models can be of help in giving realistic expectations of adult height.
BACKGROUND/AIM: To validate prediction models for near final adult height (nFAH) by Ranke et al. [Horm Res Paediatr 2013;79:51-67]. METHODS: Height data of 127 (82 male) idiopathic growth hormone (GH)-deficient children, treated with GH until nFAH, were retrieved from the database of the Belgian Society for Pediatric Endocrinology and Diabetology (BESPEED). nFAH was predicted after first-year GH treatment, applying prediction models by Ranke et al. Bland-Altman plots and Clarke error grid analyses were performed to assess clinical significance of the differences between observed and predicted nFAH. RESULTS: In males, the predicted nFAH was higher than the observed nFAH (difference: 0.2 ± 0.7 SD; p < 0.01). In females, there was no significant difference. Bland-Altman analyses showed that the means of the differences between observed and predicted nFAH were close but not equal to zero, with overprediction for smaller heights and underprediction for taller heights. Clarke error grid analysis: in males, 59-61% of the predicted nFAH were within 0.5 SDS and 88% within 1.0 SDS from the observed nFAH; in females, 40-44% of the predicted nFAH were within 0.5 SDS and 76-78% within 1.0 SDS from the observed nFAH. CONCLUSION: Ranke's models accurately predicted nFAH in females and overpredicted nFAH in males by about 1.5 cm. In most individuals, the predicted nFAH was within 1 SDS of observed nFAH. These models can be of help in giving realistic expectations of adult height.
Authors: A Carrascosa; L Audí; M Fernández-Cancio; D Yeste; M Gussinye; A Campos; M A Albisu; M Clemente; J Bel; R Nosás; M Rabanal; C Del Pozo; J M Gómez; J Mesa Journal: Horm Res Paediatr Date: 2013-03-28 Impact factor: 2.852
Authors: M Thomas; G Massa; J P Bourguignon; M Craen; J De Schepper; F de Zegher; L Dooms; M Du Caju; I François; C Heinrichs; P Malvaux; R Rooman; G Thiry-Counson; M Vandeweghe; M Maes Journal: Horm Res Date: 2001
Authors: Michael B Ranke; Anders Lindberg; Primus E Mullis; Mitchell E Geffner; Toshi Tanaka; Wayne S Cutfield; Maïthé Tauber; David Dunger Journal: Horm Res Paediatr Date: 2013-02-26 Impact factor: 2.852
Authors: J M Wit; M B Ranke; K Albertsson-Wikland; A Carrascosa; R G Rosenfeld; S Van Buuren; B Kristrom; E Schoenau; L Audi; A C S Hokken-Koelega; P Bang; H Jung; W F Blum; L A Silverman; P Cohen; S Cianfarani; C Deal; P E Clayton; L de Graaff; J Dahlgren; J Kleintjens; M Roelants Journal: Horm Res Paediatr Date: 2013-05-28 Impact factor: 2.852
Authors: Jan M. Wit; Asma Deeb; Bassam Bin-Abbas; Angham Al Mutair; Ekaterina Koledova; Martin O. Savage Journal: J Clin Res Pediatr Endocrinol Date: 2019-07-09
Authors: Aristides K Maniatis; Ulhas Nadgir; Paul Saenger; Kent L Reifschneider; Jennifer Abuzzahab; Larry Deeb; Larry A Fox; Katie A Woods; Wenjie Song; Meng Mao; Steven D Chessler; Allison S Komirenko; Aimee D Shu; Samuel J Casella; Paul S Thornton Journal: Horm Res Paediatr Date: 2022-03-09 Impact factor: 4.275
Authors: Meliha Demiral; Edip Unal; Birsen Baysal; Rıza Taner Baran; Hüseyin Demirbilek; Mehmet Nuri Özbek Journal: J Clin Res Pediatr Endocrinol Date: 2020-03-11
Authors: Paul S Thornton; Aristides K Maniatis; Elena Aghajanova; Elena Chertok; Elpis Vlachopapadopoulou; Zhengning Lin; Wenjie Song; Eva Dam Christoffersen; Vibeke Miller Breinholt; Tatiana Kovalenko; Elene Giorgadze; Maria Korpal-Szczyrska; Paul L Hofman; David B Karpf; Aimee D Shu; Michael Beckert Journal: J Clin Endocrinol Metab Date: 2021-10-21 Impact factor: 5.958